A Look At Collegium Pharmaceutical (COLL) Valuation After Recent Share Price Swings [Yahoo! Finance]
Collegium Pharmaceutical, Inc. (COLL)
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.collegiumpharma.com
Company Research
Source: Yahoo! Finance
Collegium Pharmaceutical (COLL) has been drawing investor attention after recent share moves, with the stock up about 31% over the past 3 months, even as the past month shows a 7% decline. See our latest analysis for Collegium Pharmaceutical. That recent 30.9% 3 month share price return, alongside a flat year to date move and strong 1 year total shareholder return of 36.7%, suggests earlier momentum has cooled but longer term holders have still been rewarded. If Collegium's move has you looking beyond a single pain management specialist, this could be a good moment to scan other healthcare stocks that might fit your portfolio's needs. So with Collegium trading at US$45.60, modest annual revenue growth, a much faster rise in net income, and an indicated 81% intrinsic discount, is the market presenting a buying opportunity or already pricing in future growth? With Collegium Pharmaceutical last closing at US$45.60 against a narrative fair value of about US$53.17, the widely fo
Show less
Read more
Impact Snapshot
Event Time:
COLL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COLL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COLL alerts
High impacting Collegium Pharmaceutical, Inc. news events
Weekly update
A roundup of the hottest topics
COLL
News
- Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual ConferenceGlobeNewswire
- Collegium Pharmaceutical EVP Sells COLL 17,600 Shares Amid Strong Close of 2025 [Yahoo! Finance]Yahoo! Finance
- Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now? [Yahoo! Finance]Yahoo! Finance
- Will Authorized Generic Nucynta Launch and New Credit Facility Change Collegium Pharmaceutical's (COLL) Narrative? [Yahoo! Finance]Yahoo! Finance
- Is It Time To Reassess Collegium Pharmaceutical (COLL) After Its Strong Five Year Share Price Run? [Yahoo! Finance]Yahoo! Finance
COLL
Earnings
- 11/6/25 - Beat
COLL
Sec Filings
- 1/8/26 - Form 8-K
- 12/30/25 - Form 8-K
- 12/17/25 - Form 144
- COLL's page on the SEC website